अफगान-भारत डील साइन हुई 200 मिलियन का फायदा | India Afghanistan Deal | Shubhankar Mishra |

Описание: अफगान-भारत डील साइन हुई 200 मिलियन का फायदा | India Afghanistan Deal | Shubhankar Mishra |

A massive geopolitical and economic shift is unfolding in South Asia as Afghanistan officially bans pharmaceutical imports from Pakistan, ending years of medical trade dependence. This explosive decision has opened a $200 million pharmaceutical market — and the biggest winner right now appears to be India.

In this in-depth analysis, we uncover why Afghanistan took this bold step, how Pakistan’s repeated border disruptions pushed Kabul to the edge, and why Indian pharmaceutical companies are rapidly filling the supply vacuum with affordable, high-quality medicines trusted across the world.

We also break down how Bangladesh has entered the Afghan pharma market as a backup supplier — but why experts believe it cannot compete with India on scale, cost, and manufacturing independence.

This video goes far beyond medicines.

You’ll learn:
• How Pakistan’s trade pressure strategy backfired
• Why Afghanistan is shifting its economic alliances
• How India is becoming the healthcare lifeline of the region
• What this means for Central Asia’s future trade routes
• Why this could permanently weaken Pakistan’s regional influence

We also explore how rising tensions between Iran and United States could disrupt supply chains — and why Afghanistan is preparing alternative trade routes to avoid future crises.

This is not just a pharmaceutical story.
This is a power shift in Asian trade.

If India secures Afghanistan’s trust long-term, it could unlock access to Central Asian markets worth billions — reshaping the region’s economic future.

Watch till the end to understand:
🔥 The real reason Pakistan lost Afghanistan’s pharma market
🔥 How India quietly took control of a crucial supply chain
🔥 What this means for South Asia’s balance of power

Like, share, and subscribe for more deep geopolitical breakdowns that mainstream media won’t explain clearly.